FENOFIBRATE IMPROVES LIVER BIOCHEMISTRIES IN PRIMARY BILIARY CIRRHOSIS

被引：0
|
作者：
Levy, Cynthia [1 ]
Peter, Joy A. [1 ]
Keach, Jill C. [2 ]
Petz, Janice L. [2 ]
Lindor, Keith D. [2 ]
Cabrera, Roniel [1 ]
Clark, Virginia C. [1 ]
Firpi, Roberto J. [1 ]
Morelli, Giuseppe [1 ]
Soldevila-Pico, Consuelo [1 ]
Nelson, David R. [1 ]
机构：
[1] Univ Florida, Liver Unit, Gainesville, FL USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1503
引用
收藏
页码：995A / 996A
页数：2
相关论文
共 50 条
  • [1] Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis
    Stanca, Carmen M.
    Bach, Nancy
    Allina, Jorge
    Bodian, Carol
    Bodenheimer, Henry, Jr.
    Odin, Joseph A.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1988 - 1993
  • [2] Atorvastatin Does Not Improve Liver Biochemistries or Mayo Risk Score in Primary Biliary Cirrhosis
    Carmen M. Stanca
    Nancy Bach
    Jorge Allina
    Carol Bodian
    Henry Bodenheimer
    Joseph A. Odin
    Digestive Diseases and Sciences, 2008, 53 : 1988 - 1993
  • [3] THE LONG-TERM EFFECT OF URSODEOXYCHOLIC ACID ON LIVER BIOCHEMISTRIES IN PRIMARY BILIARY CIRRHOSIS
    Kuiper, Edith M.
    Hansen, Bettina E.
    Lesterhuis, W.
    Robijn, R. J.
    Thijs, J. C.
    Engels, L. G.
    Koek, Ger H.
    Aparicio, M. N.
    Kerbert-Dreteler, M. J.
    van Buuren, Henk R.
    HEPATOLOGY, 2009, 50 (04) : 1001A - 1002A
  • [4] Fenofibrate for patients with asymptomatic primary biliary cirrhosis
    Dohmen, Kazufumi
    Mizuta, Toshihiko
    Nakamuta, Makoto
    Shimohashi, Naoya
    Ishibashi, Hiromi
    Yamamoto, Kyosuke
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (06) : 894 - 898
  • [5] Fenofibrate in Primary Biliary Cirrhosis: A Pilot Study
    Liberopoulos, E. N.
    Florentin, M.
    Elisaf, M. S.
    Mikhailidis, D. P.
    Tsianos, E.
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2010, 4 : 120 - 126
  • [6] Fenofibrate treatment in patients with primary biliary cirrhosis
    Ohira, H
    Sato, Y
    Ueno, T
    Sata, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2147 - 2149
  • [7] Fenofibrate for patients with asymptomatic primary biliary cirrhosis
    Kazufumi Dohmen Department of Internal Medicine
    World Journal of Gastroenterology, 2004, (06) : 894 - 898
  • [8] Fenofibrate improves serum distinct disease markers in patients with primary biliary cirrhosis.
    Ueno, T
    Nakamura, T
    Sakata, R
    Shishido, S
    Ohira, H
    Sata, M
    Sato, Y
    HEPATOLOGY, 2002, 36 (04) : 499A - 499A
  • [9] FENOFIBRATE IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: A PILOT STUDY
    Liberopoulos, E.
    Kitsanou, M.
    Tsianos, E.
    Elisaf, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 193 - 193
  • [10] Fenofibrate for patients with asymptomatic primary biliary cirrhosis.
    Dohmen, K
    Mizuta, T
    Nakamuta, M
    Shimohashi, N
    Ishibashi, H
    Yamamoto, K
    HEPATOLOGY, 2003, 38 (04) : 518A - 518A
12345